Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis

Ismaell Massalha, Adham Hijab, Reem Zabit, Jamal Zidan, Ory Wiesel, Nir Peled

Open source

DOI
10.1080/2162402x.2026.2756061
Published
2026-10-31
Container
OncoImmunology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/2162402x.2026.2756061,
  title = {Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis},
  author = {Ismaell Massalha and Adham Hijab and Reem Zabit and Jamal Zidan and Ory Wiesel and Nir Peled},
  year = {2026},
  journal = {OncoImmunology},
  doi = {10.1080/2162402x.2026.2756061},
  url = {https://doi.org/10.1080/2162402x.2026.2756061}
}

RIS

TY  - JOUR
TI  - Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis
AU  - Ismaell Massalha
AU  - Adham Hijab
AU  - Reem Zabit
AU  - Jamal Zidan
AU  - Ory Wiesel
AU  - Nir Peled
PY  - 2026
JO  - OncoImmunology
DO  - 10.1080/2162402x.2026.2756061
UR  - https://doi.org/10.1080/2162402x.2026.2756061
ER  - 

APA

Massalha, I., Hijab, A., Zabit, R., Zidan, J., Wiesel, O., & Peled, N. (2026). Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis. OncoImmunology. https://doi.org/10.1080/2162402x.2026.2756061

Source records